SCHEMBL9221172

SCHEMBL9221172

COC(=O)c1ccccc1CCC(SCC(C)C(=O)O)c1cccc(CCc2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9284533 0.89 — —
SCHEMBL9119951 0.88 — —
SCHEMBL9281256 0.87 — —
SCHEMBL9688190 0.87 — —
SCHEMBL13015602 0.86 PLA2G2A (0.50) —
SCHEMBL9688179 0.86 — —
SCHEMBL12927207 0.84 PLA2G2A (0.50) —
SCHEMBL9119243 0.82 — —
SCHEMBL9209227 0.81 — —
SCHEMBL9209743 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5428033-A Useful as anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotecyive agents MERCK FROSST CANADA, INC. (CA) 1995-06-27 — — US disclosed
EP-0480716-A1 Saturated hydroxyalkylquinoline acids as leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1992-04-15 — — EP disclosed
Send feedback